| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |